| Funding Opportunity |
The Effect of Different Preparation Methods on the In Vitro and In Vivo Performance of Solid Dispersion Formulations (U01) Apply for RFA FD 14 023
Funding Number: RFA FD 14 023
Agency: Food Drug Administration
Funding Amount: $500,000 |
Advancing Regulatory Science Through Development of Innovative Methodologies in the area of Antimicrobial Development (U01) Apply for RFA FD 11 026
Funding Number: RFA FD 11 026
Agency: Food Drug Administration
Funding Amount: $100,000 |
Innovation in Development and Qualification of Alternative Testing Methodologies for Reproductive Toxicology (U01) Apply for RFA FD 11 017
Funding Number: RFA FD 11 017
Agency: Food Drug Administration
Funding Amount: $350,000 |
Advancing Regulatory Science through Novel Biomarker Research and Science Based Technologies Apply for RFA FD 11 016
Funding Number: RFA FD 11 016
Agency: Food Drug Administration
Funding Amount: $350,000 |
Molybdenum 99 Apply for DE FOA 0000323
Funding Number: DE FOA 0000323
Agency: NNSA
Funding Amount: Case Dependent |
Suicide Prevention and Counseling Research Apply for W81XWH 08 MOMRP SPCR
Funding Number: W81XWH 08 MOMRP SPCR
Agency: Dept. of the Army USAMRAA
Funding Amount: $2,000,000 |
Community Health Peer Learning Program Apply for CLP CL 15 001
Funding Number: CLP CL 15 001
Agency: Office of the National Coordinator
Funding Amount: $1,700,000 |
Pharmacokinetic/Pharmacodynamic (PK/PD) Studies of Methylphenidate Extended Release Products in Attention Deficit Hyperactivity Disorder (ADHD) Patients (U01) Apply for RFA FD 14 015
Funding Number: RFA FD 14 015
Agency: Food Drug Administration
Funding Amount: $1,000,000 |
Effect of Therapeutic Class on Generic Drug Substitutions (U01) Apply for RFA FD 14 014
Funding Number: RFA FD 14 014
Agency: Food Drug Administration
Funding Amount: $400,000 |
Post market surveillance evaluation of authorized generic drug products (U01) Apply for RFA FD 14 013
Funding Number: RFA FD 14 013
Agency: Food Drug Administration
Funding Amount: $400,000 |
Prospective Studies on the Impact of Generic Immunosuppressants on Acute Rejection and Long Term Graft survivals (U01) Apply for RFA FD 14 020
Funding Number: RFA FD 14 020
Agency: Food Drug Administration
Funding Amount: $1,000,000 |
Pharmacokinetic and Pharmacodynamic (PK PD) Studies of Cardiovascular Drugs (U01) Apply for RFA FD 14 024
Funding Number: RFA FD 14 024
Agency: Food Drug Administration
Funding Amount: $1,000,000 |
Retrospective Analysis on the Impact of Generic Immunosuppressants on Acute Rejection and Long Term Graft Survivals (U01) Apply for RFA FD 14 021
Funding Number: RFA FD 14 021
Agency: Food Drug Administration
Funding Amount: $1,000,000 |
Evalution of Iron Species in Healthy Subjects treated with Generic and Reference Sodium Ferric Gluconate Apply for RFA FD 14 019
Funding Number: RFA FD 14 019
Agency: Food Drug Administration
Funding Amount: $500,000 |
Development of realistic in vitro studies to assess robustness of dose counters/indicators in metered dose inhalers (U01) Apply for RFA FD 14 025
Funding Number: RFA FD 14 025
Agency: Food Drug Administration
Funding Amount: $500,000 |
Development of Clinically Relevant in Vitro Performance Test for Generic OIDPs Physiologically Relevant Models for Aerodynamic Particle Size Distribution Analysis Apply for RFA FD 14 022
Funding Number: RFA FD 14 022
Agency: Food Drug Administration
Funding Amount: $500,000 |
Evaluation of in vitro release methods for liposomal drug products Apply for RFA FD 14 016
Funding Number: RFA FD 14 016
Agency: Food Drug Administration
Funding Amount: $500,000 |
Dissolution Methods for Suspension and Emulsion Ocular Drug Products Apply for RFA FD 14 009
Funding Number: RFA FD 14 009
Agency: Food Drug Administration
Funding Amount: $250,000 |
Dissolution Methods for Microsphere and Implant Drug Products Apply for RFA FD14 007
Funding Number: RFA FD14 007
Agency: Food Drug Administration
Funding Amount: $500,000 |
Dissolution Methods for Semisolid Ocular Drug Products Apply for RFA FD 14 008
Funding Number: RFA FD 14 008
Agency: Food Drug Administration
Funding Amount: $350,000 |
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products Apply for RFA FD 14 010
Funding Number: RFA FD 14 010
Agency: Food Drug Administration
Funding Amount: $250,000 |
Pharmacometric Modeling and Simulation for Generic Drugs Evaluation Apply for RFA FD 14 011
Funding Number: RFA FD 14 011
Agency: Food Drug Administration
Funding Amount: $250,000 |
Physiologically Based Absorption and Pharmacokinetic Modeling and Simulation for Non gastrointestinally Absorbed Drug Products In Humans Apply for RFA FD 14 012
Funding Number: RFA FD 14 012
Agency: Food Drug Administration
Funding Amount: $200,000 |
In vitro release tests for topical dermatological products (U01) Apply for RFA FD 13 016
Funding Number: RFA FD 13 016
Agency: Food Drug Administration
Funding Amount: $500,000 |
In vitro release tests for transdermal drug delivery systems (U01) Apply for RFA FD 13 015
Funding Number: RFA FD 13 015
Agency: Food Drug Administration
Funding Amount: $500,000 |
Systematic Evaluation of Excipient Effects on the Efficacy of Metered Dose Inhaler Products (U01) Apply for RFA FD 13 013
Funding Number: RFA FD 13 013
Agency: Food Drug Administration
Funding Amount: $500,000 |
Development of in vivo predictive dissolution method for orally inhaled drug products Apply for RFA FD 13 014
Funding Number: RFA FD 13 014
Agency: Food Drug Administration
Funding Amount: $200,000 |
